Clinical And Economic Impact Of Upfront Plerixafor In Autologous Transplantation.
Phase of Trial: Phase IV
Latest Information Update: 04 Aug 2017
At a glance
- Drugs Filgrastim (Primary) ; Plerixafor (Primary)
- Indications Multiple myeloma; Non-Hodgkin's lymphoma
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 29 Apr 2016 Status changed from active, no longer recruiting to completed.
- 05 Jun 2015 Planned End Date changed from 1 Apr 2015 to 1 Jul 2016, as reported by ClinicalTrials.gov record.